Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Keely Hack

1PUBLICATIONS
14CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 01, 2023
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With <i>ATM</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

Nitin Rohatgi, Michael Rothe, Pam K Mangat

Pageof 1

Frequent Collaborators

1 joint publications

Pam K Mangat

1 joint publications

Elizabeth Garrett-Mayer

1 joint publications

Funda Meric-Bernstam

1 joint publications

Olatunji B Alese

1 joint publications

Ramya Thota

1 joint publications

Gina M Vaccaro

1 joint publications

Margaret von Mehren

1 joint publications

Alissa S Marr

1 joint publications

Arthur Winer

1 joint publications

Gina N Grantham

Frequent Collaborators

1 joint publications

Pam K Mangat

1 joint publications

Elizabeth Garrett-Mayer

1 joint publications

Funda Meric-Bernstam

1 joint publications

Olatunji B Alese

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.4K
See more related videos